Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024

247updates 2 months ago

Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth’s pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma, and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19....CONTINUE READING

PAY ATTENTION: Mistakes Cancer Patients Should Not Make To Avoid Worsening The Condition

Prev Article Next Article

Please Enable JavaScript in your Browser to Visit this Site.

#t42-content-defender-js-disabled { position: fixed; top: 0; left: 0; height: 100%; width: 100%; z-index: 999999; text-align: center; background-color: #FFFFFF; color: #000000; font-size: 40px; display: flex; align-items: center; justify-content: center; }

Related Posts